VWF (von Willebrand factor) variants and mutations
VWF (also known as von Willebrand factor) is a human protein-coding gene encoding a von Willebrand factor protein. It tethers platelets to damaged vessel walls and carries factor VIII in the circulation, linking primary hemostasis with coagulation. Quantitative or qualitative pathogenic variants cause von Willebrand disease, the most common inherited bleeding disorder. This analysis covers 3,766 VWF variants and mutations. Of these, 92% have computational variant effect predictions. Disease context includes Von Willebrand disease, von Willebrand disease 3, and von Willebrand disease 2. Example VWF variants include P3S, R5G, and R5I.
Variant analysis overview
- Gene: VWF
- Protein: von Willebrand factor
- UniProt accession: P04275
- Organism: Homo sapiens
- Variants analyzed: 3766
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 3,577 unspecified-consequence records; 74 synonymous variants; 89 missense variants; 4 splice-region variants; 3 in-frame deletions; 16 frameshift variants; 2 stop-gained variants; 1 substitution
- Prediction scores: 3,463 variants have prediction scores (92% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Von Willebrand disease, von Willebrand disease 3, von Willebrand disease 2, Von Willebrand disease type 1, von Willebrand disease type 2B, Von Willebrand disease type 2, von Willebrand disease 1, von Willebrand disease (hereditary or acquired), hereditary von Willebrand disease, von Willebrand disease type 2A, von Willebrand disease type 2M, von Willebrand disease type 2N.
Protein structure and variant hotspots
- Protein features: 15 domains; 26 post-translational modification sites.
- Structural context: 2,279 variants have structural context.
- PTM context: 41 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable VWF variants
Examples include P3S, R5G, R5I, F6C, F6L, A7V, G8E, G8R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- P3S (p.Pro3Ser), TOPMed rs1314021275, gnomAD rs1314021275, REVEL 0.07, MetaLR 0.16
- R5G (p.Arg5Gly), TOPMed rs1945449730, REVEL 0.04, MetaLR 0.07
- R5I (p.Arg5Ile), Ensembl rs1945449700, REVEL 0.10, MetaLR 0.11
- F6C (p.Phe6Cys), TOPMed rs1478605207, gnomAD rs1478605207, REVEL 0.06, MetaLR 0.06
- F6L (p.Phe6Leu), TOPMed rs1374009057, gnomAD rs1374009057, REVEL 0.01, MetaLR 0.02
- A7V (p.Ala7Val), Ensembl rs866946680, MetaLR 0.05, MetaSVM -1.07
- G8E (p.Gly8Glu), NCI-TCGA Cosmic COSV9977, Variant assessed as somatic; moderate impact.
- G8R (p.Gly8Arg), rs201015235, ClinGen CA6403990, ClinVar RCV002481154, ClinVar RCV003485788, REVEL 0.05, MetaLR 0.02, Uncertain significance, not provided; von Willebrand disease type 1
- G8W (p.Gly8Trp), ESP rs201015235, ExAC rs201015235, TOPMed rs201015235, gnomAD rs201015235, REVEL 0.04, MetaLR 0.05, Uncertain significance
- V9G (p.Val9Gly), gnomAD rs1945449461, REVEL 0.14, MetaLR 0.10
- V9L (p.Val9Leu), rs768885457, ExAC rs768885457, TOPMed rs768885457, gnomAD rs768885457, REVEL 0.03, MetaLR 0.05, Uncertain significance, not provided
- V9M (p.Val9Met), ExAC rs768885457, TOPMed rs768885457, gnomAD rs768885457, REVEL 0.06, MetaLR 0.09, Uncertain significance
- L10P (p.Leu10Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L11F (p.Leu11Phe), Ensembl rs1945449364
- A12P (p.Ala12Pro), TOPMed rs1945449340, REVEL 0.22, MetaLR 0.14
- A14D (p.Ala14Asp), ExAC rs747049949, TOPMed rs747049949, gnomAD rs747049949, REVEL 0.10, MetaLR 0.11
- I16V (p.Ile16Val), TOPMed rs1945449279, REVEL 0.03, MetaLR 0.05
- L17F (p.Leu17Phe), TOPMed rs1295142745, gnomAD rs1295142745, REVEL 0.12, MetaLR 0.08
- G19E (p.Gly19Glu), ExAC rs267603621, TOPMed rs267603621, gnomAD rs267603621, REVEL 0.23, MetaLR 0.18
- G19R (p.Gly19Arg), rs61753983, ClinGen CA228729, ClinVar RCV000086844, ClinVar RCV002264667, REVEL 0.26, MetaLR 0.20, Conflicting interpretations, von Willebrand disease type 1; von Willebrand disease type 3; not specified
- L21F (p.Leu21Phe), TOPMed rs1248200326, gnomAD rs1248200326, REVEL 0.02, MetaLR 0.07
- A23V (p.Ala23Val), NCI-TCGA Cosmic COSV9977, REVEL 0.01, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- G25R (p.Gly25Arg), ExAC rs768896863, gnomAD rs768896863, REVEL 0.02, MetaLR 0.08
- T26S (p.Thr26Ser), rs747404115, ClinGen CA6403904, ClinVar RCV000759407, ExAC rs747404115, REVEL 0.03, MetaLR 0.07, Uncertain significance, not provided
- R27C (p.Arg27Cys), TOPMed rs1373999500, gnomAD rs1373999500, REVEL 0.01, MetaLR 0.05
- R27H (p.Arg27His), ExAC rs773817619, TOPMed rs773817619, gnomAD rs773817619, REVEL 0.03, MetaLR 0.04, Uncertain significance, not provided
- G28R (p.Gly28Arg), NCI-TCGA Cosmic COSV5461, ExAC rs777235699, TOPMed rs777235699, gnomAD rs777235699, Uncertain significance, Inborn genetic diseases
- G28S (p.Gly28Ser), ExAC rs777235699, TOPMed rs777235699, gnomAD rs777235699, REVEL 0.00, MetaLR 0.05, Uncertain significance
- R29K (p.Arg29Lys), ExAC rs755672837, gnomAD rs755672837, REVEL 0.01, MetaLR 0.04
- R29W (p.Arg29Trp), TOPMed rs1945428894, MetaLR 0.05, MetaSVM -1.06
- S30* (p.Ser30Ter), gnomAD rs1468538045, CADD 34.00
- S30A (p.Ser30Ala), Ensembl rs1591930443
- T32A (p.Thr32Ala), TOPMed rs772515993, gnomAD rs772515993, REVEL 0.01, MetaLR 0.05, Uncertain significance, Inborn genetic diseases
- T32M (p.Thr32Met), 1000Genomes rs537944350, ExAC rs537944350, TOPMed rs537944350, gnomAD rs537944350, REVEL 0.01, MetaLR 0.03
- A33P (p.Ala33Pro), 1000Genomes rs368132716, ESP rs368132716, ExAC rs368132716, TOPMed rs368132716, REVEL 0.25, MetaLR 0.17, Uncertain significance, not provided
- A33V (p.Ala33Val), Ensembl rs1945428586, MetaLR 0.19, MetaSVM -0.81
- R34* (p.Arg34Ter), rs61753984, ClinGen CA228255, NCI-TCGA Cosmic COSV1043, NCI-TCGA Cosmic COSV5463, CADD 37.00, Pathogenic
- R34G (p.Arg34Gly), rs61753984, ClinGen CA228253, ClinVar RCV000086553, ExAC rs61753984, REVEL 0.34, MetaLR 0.27, not provided
- R34Q (p.Arg34Gln), ExAC rs766468461, TOPMed rs766468461, gnomAD rs766468461, REVEL 0.23, MetaLR 0.25
- S36N (p.Ser36Asn), ESP rs374601266, ExAC rs374601266, TOPMed rs374601266, gnomAD rs374601266, REVEL 0.41, MetaLR 0.46
- S36R (p.Ser36Arg), ExAC rs750720570, gnomAD rs750720570, REVEL 0.44, MetaLR 0.35
- S36T (p.Ser36Thr), ESP rs374601266, ExAC rs374601266, TOPMed rs374601266, gnomAD rs374601266, REVEL 0.22, MetaLR 0.29
- G39E (p.Gly39Glu), ExAC rs762049443, gnomAD rs762049443, REVEL 0.66, MetaLR 0.59
- G39R (p.Gly39Arg), rs1397778191, ClinGen CA383508636, NCI-TCGA Cosmic COSV5462, NCI-TCGA Cosmic COSV9978, REVEL 0.68, MetaLR 0.64, Likely pathogenic, not provided
- S40I (p.Ser40Ile), 1000Genomes rs138001833, ExAC rs138001833, TOPMed rs138001833, gnomAD rs138001833, REVEL 0.19, MetaLR 0.16
- S40N (p.Ser40Asn), 1000Genomes rs138001833, ExAC rs138001833, TOPMed rs138001833, gnomAD rs138001833, REVEL 0.03, MetaLR 0.07
- F42L (p.Phe42Leu), rs200710351, ClinGen CA232319470, ClinVar RCV004554519, ExAC rs200710351, REVEL 0.13, MetaLR 0.28, Uncertain significance, VWF-related disorder
- V43F (p.Val43Phe), NCI-TCGA Cosmic COSV5462, Variant assessed as somatic; moderate impact.
- V43I (p.Val43Ile), rs772466729, NCI-TCGA Cosmic COSV5462, ExAC rs772466729, TOPMed rs772466729, REVEL 0.06, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- N44S (p.Asn44Ser), gnomAD rs1012488531, REVEL 0.09, MetaLR 0.24
- N44T (p.Asn44Thr), gnomAD rs1012488531, REVEL 0.11, MetaLR 0.18
- D47H (p.Asp47His), rs61753985, ClinGen CA228271, ClinVar RCV000086564, Ensembl rs61753985, MutPred 0.88, not provided
- S49R (p.Ser49Arg), TOPMed rs1195660161, gnomAD rs1195660161, REVEL 0.15, MetaLR 0.14, Uncertain significance, von Willebrand disease type 1; von Willebrand disease type 3; von Willebrand dis
- M50T (p.Met50Thr), Ensembl rs958629333, REVEL 0.28, MetaLR 0.25
- M50V (p.Met50Val), rs2136535487, ClinGen CA383508215, ClinVar RCV001801310, Ensembl rs2136535487, MutPred 0.52, Uncertain significance, von Willebrand disease type 2
- Y51H (p.Tyr51His), NCI-TCGA Cosmic COSV5462, Variant assessed as somatic; moderate impact.
- S52C (p.Ser52Cys), ExAC rs747701551, gnomAD rs747701551, REVEL 0.45, MetaLR 0.42
- F53S (p.Phe53Ser), gnomAD rs1479532600, REVEL 0.69, MetaLR 0.57
- A54E (p.Ala54Glu), rs200901782, ClinGen CA383508078, ClinVar RCV001820548, ExAC rs200901782, MutPred 0.57, Uncertain significance, not specified
- A54V (p.Ala54Val), rs200901782, ClinGen CA6403881, ClinVar RCV003443562, ClinVar RCV005515562, REVEL 0.05, MetaLR 0.13, Uncertain significance, not provided; Inborn genetic diseases
- Y56* (p.Tyr56Ter), rs1945427535, ClinGen CA383507956, ClinVar RCV003134765, Likely pathogenic
- Y56C (p.Tyr56Cys), gnomAD rs1301367628, REVEL 0.18, MetaLR 0.14
- Y56H (p.Tyr56His), TOPMed rs1945427601, REVEL 0.16, MetaLR 0.13
- C57* (p.Cys57Ter), rs61753987, ClinGen CA228282, ClinVar RCV000086573, gnomAD rs61753987, MutPred 0.85, Uncertain significance
- C57S (p.Cys57Ser), ExAC rs779874391, gnomAD rs779874391, REVEL 0.65, MetaLR 0.57
- C57W (p.Cys57Trp), rs61753987, ClinGen CA383507922, ClinVar RCV002657135, ClinVar RCV006451337, REVEL 0.63, MetaLR 0.53, Uncertain significance, Inborn genetic diseases; not provided
- Y59H (p.Tyr59His), ExAC rs758324527, REVEL 0.73, MetaLR 0.62
- L60F (p.Leu60Phe), Ensembl rs1945427387
- L61P (p.Leu61Pro), rs1306914162, ClinGen CA383507786, ClinVar RCV000852058, gnomAD rs1306914162, REVEL 0.70, MetaLR 0.62, Uncertain significance, Hereditary von Willebrand disease
- A62E (p.Ala62Glu), NCI-TCGA TCGA novel, REVEL 0.57, MetaLR 0.57, Variant assessed as somatic; moderate impact.
- A62T (p.Ala62Thr), TOPMed rs906927941
- G64A (p.Gly64Ala), Ensembl rs1591930324, MetaLR 0.09, MetaSVM -0.97
- Q66H (p.Gln66His), NCI-TCGA Cosmic COSV5461, Variant assessed as somatic; moderate impact.
- Q66K (p.Gln66Lys), TOPMed rs892950501, REVEL 0.12, MetaLR 0.13, Uncertain significance, Inborn genetic diseases
- Q66R (p.Gln66Arg), ExAC rs765560613, gnomAD rs765560613, REVEL 0.12, MetaLR 0.13
- R68C (p.Arg68Cys), rs757353387, ClinGen CA6403874, NCI-TCGA Cosmic COSV5461, ClinVar RCV003988558, REVEL 0.43, MetaLR 0.41, Uncertain significance, not specified; not provided
- R68H (p.Arg68His), ExAC rs753973552, gnomAD rs753973552, REVEL 0.06, MetaLR 0.06
- R68P (p.Arg68Pro), NCI-TCGA Cosmic COSV5461, MetaLR 0.23, MetaSVM -0.76, Variant assessed as somatic; moderate impact.
- S69F (p.Ser69Phe), Ensembl rs1945426980, MetaLR 0.43, MetaSVM -0.07
- F70L (p.Phe70Leu), NCI-TCGA Cosmic COSV9978, MetaLR 0.42, MetaSVM -0.25, Variant assessed as somatic; moderate impact.
- S71* (p.Ser71Ter), rs62643619, ClinGen CA228310, ClinVar RCV000086590, ClinVar RCV004771460, Likely pathogenic
- S71L (p.Ser71Leu), rs62643619, ClinGen CA6403871, ClinVar RCV004552517, ExAC rs62643619, REVEL 0.40, MetaLR 0.41, Uncertain significance, VWF-related disorder
- I73F (p.Ile73Phe), Ensembl rs921931922, REVEL 0.10, MetaLR 0.14
- G74=, rs756159469, NCI-TCGA Cosmic COSV5462, Variant assessed as somatic; low impact.
- G74A (p.Gly74Ala), ExAC rs777859406, TOPMed rs777859406, gnomAD rs777859406, REVEL 0.18, MetaLR 0.18
- G74R (p.Gly74Arg), rs2136535320, ClinGen CA383507438, ClinVar RCV001787173, ClinVar RCV006258565, MutPred 0.68, Uncertain significance, not provided
- Q77* (p.Gln77Ter), rs2136522827, ClinGen CA383519645, ClinVar RCV001787188, Ensembl rs2136522827, Pathogenic
- N78S (p.Asn78Ser), ExAC rs768075585, gnomAD rs768075585, REVEL 0.08, MetaLR 0.22
- G79V (p.Gly79Val), rs1020664699, ClinGen CA232363901, ClinVar RCV003239201, ClinVar RCV004801333, REVEL 0.48, MetaLR 0.41, Uncertain significance, not provided; not specified
- K80N (p.Lys80Asn), Ensembl rs2136522815, REVEL 0.02, MetaLR 0.14
- K80T (p.Lys80Thr), NCI-TCGA TCGA novel, MetaLR 0.21, MetaSVM -0.86, Variant assessed as somatic; moderate impact.
- R81K (p.Arg81Lys), gnomAD rs1274318204, REVEL 0.08, MetaLR 0.21
- V82A (p.Val82Ala), TOPMed rs1233127757, gnomAD rs1233127757, REVEL 0.09, MetaLR 0.18, Uncertain significance, Inborn genetic diseases
- V82E (p.Val82Glu), TOPMed rs1233127757, gnomAD rs1233127757, REVEL 0.25, MetaLR 0.19
- S83R (p.Ser83Arg), TOPMed rs1335972884, gnomAD rs1335972884, REVEL 0.32, MetaLR 0.26, Uncertain significance, not provided
- L84F (p.Leu84Phe), rs372664002, ClinGen CA6403851, ClinVar RCV000520820, ESP rs372664002, REVEL 0.17, MetaLR 0.25, Uncertain significance, not provided
- S85P (p.Ser85Pro), rs62643620, ClinGen CA228348, ClinVar RCV000086617, Ensembl rs62643620, MutPred 0.76, not provided
- V86E (p.Val86Glu), rs2497300203, ClinGen CA383519542, ClinVar RCV004550896, REVEL 0.57, MetaLR 0.52, Likely pathogenic, VWF-related disorder
- V86M (p.Val86Met), rs140044866, ESP rs140044866, ExAC rs140044866, TOPMed rs140044866, REVEL 0.38, MetaLR 0.45, Variant assessed as somatic; moderate impact.
- Y87S (p.Tyr87Ser), rs62643621, ClinGen CA228355, ClinVar RCV000086622, TOPMed rs62643621, REVEL 0.38, MetaLR 0.28, not provided
- L88I (p.Leu88Ile), TOPMed rs996706475, gnomAD rs996706475, REVEL 0.24, MetaLR 0.30, Uncertain significance, Inborn genetic diseases
- L88V (p.Leu88Val), TOPMed rs996706475, gnomAD rs996706475, REVEL 0.33, MetaLR 0.35, Uncertain significance, Inborn genetic diseases
- G89E (p.Gly89Glu), Ensembl rs751410490
- E90D (p.Glu90Asp), rs1204340960, ClinGen CA383519499, ClinVar RCV003315194, ClinVar RCV003384366, REVEL 0.21, MetaLR 0.13, Uncertain significance, von Willebrand disease type 1; Inborn genetic diseases
- F91C (p.Phe91Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F91I (p.Phe91Ile), ExAC rs760170954, TOPMed rs760170954, gnomAD rs760170954, REVEL 0.23, MetaLR 0.28
- F91L (p.Phe91Leu), TOPMed rs1321776726, MetaLR 0.22, MetaSVM -0.68
- F92S (p.Phe92Ser), NCI-TCGA Cosmic COSV9977, MetaLR 0.44, MetaSVM -0.05, Variant assessed as somatic; moderate impact.
- D93* (p.Asp93Ter), rs61753988, ClinGen CA228364, ClinVar RCV000086629, ClinVar RCV002466428, CADD 23.90, Pathogenic
- H95R (p.His95Arg), TOPMed rs1415405296, gnomAD rs1415405296, REVEL 0.25, MetaLR 0.21
- N99I (p.Asn99Ile), TOPMed rs1437432449, MetaLR 0.38, MetaSVM -0.15
- T101A (p.Thr101Ala), gnomAD rs1475875021, REVEL 0.10, MetaLR 0.24
- V102M (p.Val102Met), rs147514785, ClinGen CA6403841, ClinVar RCV001553119, ClinVar RCV004587178, REVEL 0.25, MetaLR 0.43, Uncertain significance, Hereditary von Willebrand disease
- T103K (p.Thr103Lys), ExAC rs770652563, MetaLR 0.17, MetaSVM -1.00
- Q104* (p.Gln104Ter), rs2136522699, ClinGen CA383519226, ClinVar RCV001787213, Ensembl rs2136522699, CADD 38.00, Pathogenic
- G105R (p.Gly105Arg), ExAC rs777859270, gnomAD rs777859270
- D106A (p.Asp106Ala), TOPMed rs1428358025, gnomAD rs1428358025, REVEL 0.13, MetaLR 0.13
- D106G (p.Asp106Gly), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -0.99, Variant assessed as somatic; moderate impact.
- D106N (p.Asp106Asn), TOPMed rs1945300348, REVEL 0.06, MetaLR 0.14
- R108* (p.Arg108Ter), rs2136522667, ClinGen CA383519152, ClinVar RCV001774769, Ensembl rs2136522667, Pathogenic
- R108I (p.Arg108Ile), TOPMed rs1945300286, MetaLR 0.16, MetaSVM -0.98
- S110A (p.Ser110Ala), Ensembl rs1591924432, REVEL 0.23, MetaLR 0.36
- S110F (p.Ser110Phe), ExAC rs769955003, gnomAD rs769955003, REVEL 0.47, MetaLR 0.50
- M111I (p.Met111Ile), Ensembl rs1945297597, REVEL 0.08, MetaLR 0.06
- M111K (p.Met111Lys), gnomAD rs1349554783, REVEL 0.40, MetaLR 0.22
- M111L (p.Met111Leu), TOPMed rs1262180179, gnomAD rs1262180179, REVEL 0.05, MetaLR 0.04
- M111T (p.Met111Thr), gnomAD rs1349554783, REVEL 0.20, MetaLR 0.11
- P112S (p.Pro112Ser), gnomAD rs1280452644, REVEL 0.73, MetaLR 0.55
- Y113C (p.Tyr113Cys), rs374854636, ClinGen CA232363434, ClinVar RCV001284260, ClinVar RCV002537931, REVEL 0.55, MetaLR 0.44, Conflicting interpretations, Inborn genetic diseases; not provided; von Willebrand disease type 1
- A114P (p.Ala114Pro), NCI-TCGA Cosmic COSV5461, Variant assessed as somatic; moderate impact.
- A114V (p.Ala114Val), rs1365449398, NCI-TCGA Cosmic COSV5462, TOPMed rs1365449398, gnomAD rs1365449398, REVEL 0.42, MetaLR 0.36, Uncertain significance, not provided; not specified
- S115A (p.Ser115Ala), NCI-TCGA Cosmic COSV9977, Variant assessed as somatic; moderate impact.
- K116N (p.Lys116Asn), gnomAD rs1281205147, REVEL 0.05, MetaLR 0.06
- K116R (p.Lys116Arg), Ensembl rs1945297416, REVEL 0.04, MetaLR 0.12, Uncertain significance, Inborn genetic diseases
- G117R (p.Gly117Arg), rs748190942, ClinGen CA6403818, ClinVar RCV004485320, ClinVar RCV004783138, REVEL 0.63, MetaLR 0.50, Uncertain significance, not specified; Inborn genetic diseases
- L118P (p.Leu118Pro), rs2497299317, ClinGen CA383518925, ClinVar RCV003994957, Uncertain significance, not specified
- Y119C (p.Tyr119Cys), gnomAD rs1305880207, REVEL 0.35, MetaLR 0.39
- Y119H (p.Tyr119His), NCI-TCGA Cosmic COSV5463, Uncertain significance, Inborn genetic diseases
- L120V (p.Leu120Val), ExAC rs777585191, TOPMed rs777585191, gnomAD rs777585191, REVEL 0.05, MetaLR 0.16, Uncertain significance, not provided
- E123K (p.Glu123Lys), NCI-TCGA Cosmic COSV5461, Variant assessed as somatic; moderate impact.
- A124S (p.Ala124Ser), Ensembl rs1455811716, MetaLR 0.29, MetaSVM -0.76
- Y126C (p.Tyr126Cys), gnomAD rs1004001002, REVEL 0.40, MetaLR 0.40
- Y126F (p.Tyr126Phe), gnomAD rs1004001002, MetaLR 0.16, MetaSVM -0.98
- Y127C (p.Tyr127Cys), gnomAD rs1410879724, REVEL 0.48, MetaLR 0.46
- K128R (p.Lys128Arg), NCI-TCGA Cosmic COSV9977, gnomAD rs1945296746, REVEL 0.17, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- L129M (p.Leu129Met), rs61753991, ClinGen CA228468, ClinVar RCV000086692, ClinVar RCV004739356, REVEL 0.38, MetaLR 0.26, Conflicting interpretations, not provided
- S130C (p.Ser130Cys), TOPMed rs1433436236, gnomAD rs1433436236, REVEL 0.38, MetaLR 0.44
- G131C (p.Gly131Cys), 1000Genomes rs76505074, ESP rs76505074, ExAC rs76505074, TOPMed rs76505074, Benign
- G131S (p.Gly131Ser), rs76505074, ClinGen CA6403810, ClinVar RCV000246724, ClinVar RCV000382333, REVEL 0.14, MetaLR 0.01, Likely benign, Hereditary von Willebrand disease
- A133S (p.Ala133Ser), TOPMed rs1190459219, gnomAD rs1190459219, MetaLR 0.13, MetaSVM -0.97
- A133T (p.Ala133Thr), TOPMed rs1190459219, gnomAD rs1190459219, REVEL 0.05, MetaLR 0.11
- Y134C (p.Tyr134Cys), gnomAD rs1486478814, REVEL 0.40, MetaLR 0.40
- G135S (p.Gly135Ser), gnomAD rs1945296189, REVEL 0.53, MetaLR 0.48
- G135V (p.Gly135Val), gnomAD rs1209608007, MetaLR 0.49, MetaSVM 0.06
- F136S (p.Phe136Ser), gnomAD rs1309918137, REVEL 0.70, MetaLR 0.43
- V137L (p.Val137Leu), rs71582882, ClinGen CA6403809, ClinVar RCV003477403, ClinVar RCV005240784, REVEL 0.10, MetaLR 0.26, Conflicting interpretations, not provided; not specified
- A138D (p.Ala138Asp), rs932271358, NCI-TCGA Cosmic COSV9978, TOPMed rs932271358, Variant assessed as somatic; moderate impact.
- A138V (p.Ala138Val), rs932271358, ClinGen CA383518582, ClinVar RCV002683998, MutPred 0.63, Uncertain significance, Inborn genetic diseases
- R139G (p.Arg139Gly), 1000Genomes rs545695166, ExAC rs545695166, gnomAD rs545695166, REVEL 0.40, MetaLR 0.36
- I140F (p.Ile140Phe), 1000Genomes rs148218885, ESP rs148218885, ExAC rs148218885, TOPMed rs148218885, REVEL 0.30, MetaLR 0.24
- I140V (p.Ile140Val), 1000Genomes rs148218885, ESP rs148218885, ExAC rs148218885, TOPMed rs148218885, REVEL 0.13, MetaLR 0.23
- D141G (p.Asp141Gly), rs61753993, ClinGen CA228563, ClinVar RCV000086746, Ensembl rs61753993, MutPred 0.78, not provided
- D141N (p.Asp141Asn), rs61753992, ClinGen CA228557, ClinVar RCV000086743, ClinVar RCV000852120, MutPred 0.79, Pathogenic/Likely pathogenic, Hereditary von Willebrand disease; von Willebrand disease type 1
- D141Y (p.Asp141Tyr), rs61753992, ClinGen CA228559, ClinVar RCV000086744, Ensembl rs61753992, REVEL 0.53, MetaLR 0.55, not provided
- S143R (p.Ser143Arg), 1000Genomes rs202062122, ExAC rs202062122, TOPMed rs202062122, gnomAD rs202062122
- G144S (p.Gly144Ser), rs781180895, NCI-TCGA Cosmic COSV5463, ExAC rs781180895, TOPMed rs781180895, REVEL 0.22, MetaLR 0.34, Uncertain significance
- N145K (p.Asn145Lys), rs1591924311, ClinGen CA383518460, ClinVar RCV000851790, ClinVar RCV001284373, REVEL 0.34, MetaLR 0.29, Uncertain significance, Hereditary von Willebrand disease; not provided
- Q147* (p.Gln147Ter), 1000Genomes rs199939434, ExAC rs199939434, gnomAD rs199939434
- Q147R (p.Gln147Arg), gnomAD rs1483313796, REVEL 0.28, MetaLR 0.37
- V148F (p.Val148Phe), Ensembl rs1945295333
- L150P (p.Leu150Pro), rs61753994, ClinGen CA228603, ClinVar RCV000086768, ClinVar RCV000851799, REVEL 0.71, MetaLR 0.53, Likely pathogenic, Hereditary von Willebrand disease
- L150Q (p.Leu150Gln), rs61753994, ClinGen CA228601, ClinVar RCV000086767, gnomAD rs61753994, MutPred 0.71, not provided
- L150V (p.Leu150Val), ExAC rs768721653, gnomAD rs768721653, REVEL 0.35, MetaLR 0.26
- D152E (p.Asp152Glu), ExAC rs747152070, TOPMed rs747152070, gnomAD rs747152070
- D152G (p.Asp152Gly), TOPMed rs1328350286, gnomAD rs1328350286, REVEL 0.17, MetaLR 0.14
- D152H (p.Asp152His), gnomAD rs754806588, REVEL 0.10, MetaLR 0.24
- R153K (p.Arg153Lys), TOPMed rs928730817, gnomAD rs928730817, REVEL 0.11, MetaLR 0.18
- R153S (p.Arg153Ser), gnomAD rs1945295126, REVEL 0.24, MetaLR 0.21
- Y154C (p.Tyr154Cys), TOPMed rs940748585, gnomAD rs940748585, REVEL 0.36, MetaLR 0.51
- Y154S (p.Tyr154Ser), NCI-TCGA Cosmic COSV5461, MetaLR 0.51, MetaSVM -0.44, Variant assessed as somatic; moderate impact.
Public VWF analysis runs
- VWF analysis run — VWF (3,766 variants) — completed 2026-08-19